Log in
Enquire now

List of SBIR/STTR awards granted to American Life Science Pharmaceuticals

List of SBIR/STTR awards granted to American Life Science Pharmaceuticals
List of SBIR/STTR awards granted to ENERGY QUEST TECHNOLOGIES INC
List of SBIR/STTR awards granted to SIGMA SYSTEMS RESEARCH, INC.
List of SBIR/STTR awards granted to Visible Productions LLC
List of companies in Cultivation Capital's investment portfolio
CEOs of open access companies
where
SBIR/STTR Award Recipient
is
‌
American Life Science Pharmaceuticals
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC. STTR Phase I Award, September 2018

A STTR Phase I contract was awarded to American Life Science Pharmaceuticals in September, 2018 for $623,350.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
American Life Science Pharmaceuticals
National Institutes of Health
National Institutes of Health
STTR
1R41NS110147-01
Phase I
623,350
September 30, 2018
sbir.gov/node/1571753
‌
AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to American Life Science Pharmaceuticals for $157,550.0 USD from the U.S. Department of Health & Human Services.

‌
American Life Science Pharmaceuticals
SBIR
1R43DA018007-01
Phase I
157,550
sbir.gov/content/drugs-elevate-enkephalin-novel-opiate-analgesics-0
‌
AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to American Life Science Pharmaceuticals for $1,541,520.0 USD from the U.S. Department of Health & Human Services.

‌
American Life Science Pharmaceuticals
SBIR
2R44AG018280-02A1
Phase II
1,541,520
sbir.gov/content/gamma-secretase-assays-discover-drugs-alzheimers-0
‌
AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to American Life Science Pharmaceuticals for $115,137.0 USD from the U.S. Department of Health & Human Services.

‌
American Life Science Pharmaceuticals
SBIR
1R44AG032784-01
Phase I
115,137
sbir.gov/content/development-e64d-alzheimers-disease-2
‌
AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to American Life Science Pharmaceuticals for $95,089.0 USD from the U.S. Department of Health & Human Services.

‌
American Life Science Pharmaceuticals
SBIR
1R44AG030865-01A1
Phase I
95,089
sbir.gov/content/development-protease-inhibitor-drugs-treat-alzheimers-disease-2
‌
AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to American Life Science Pharmaceuticals for $1,148,520.0 USD from the U.S. Department of Health & Human Services.

‌
American Life Science Pharmaceuticals
SBIR
4R44AG032784-02
Phase II
1,148,520
sbir.gov/content/development-e64d-alzheimers-disease-0
‌
AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to American Life Science Pharmaceuticals for $1,144,770.0 USD from the U.S. Department of Health & Human Services.

‌
American Life Science Pharmaceuticals
SBIR
4R44AG030865-02
Phase II
1,144,770
sbir.gov/content/development-protease-inhibitor-drugs-treat-alzheimers-disease-0
7 results
0 selected
7 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us